Brain stimulation in psychiatry: ECT, DBS, TMS and other modalities

Brain Stimulation in Psychiatry: ECT, DBS, TMS and Other Modalities

Volumn , Issue , 2012, Pages 1-148

  Kellner, Charles H ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84924090952     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1017/CBO9780511736216     Document Type: Book

References (365)

1. Abrams, R. 2002. Electroconvulsive Therapy. New York: Oxford University Press.
2. American Psychiatric Association. 2001. Task Force on Electroconvulsive Therapy. The Practice of Electroconvulsive Therapy: Recommendations for Treatment, Training, and Privileging. Washington, DC: American Psychiatric Association.
3. Beale, M. D., Kellner, C. H., Pritchett, J. T., et al. 1994. Stimulus dose-titration in ECT: A 2-year clinical experience. Convuls Ther, 10, 171-6.
4. Bolwig, T. G., Hertz, M. M., & Holm-Jensen, J. 1977. Blood-brain barrier during electroshock seizures in the rat. Eur J Clin Invest, 7, 95-100.
5. Bolwig, T. G., & Madsen, T. M. 2007. Electroconvulsive therapy in melancholia: The role of hippocampal neurogenesis. Acta Psychiatr Scand Suppl, 130-5.
6. Bourgon, L. N., & Kellner, C. H. 2000. Relapse of depression after ECT: A review. J ECT, 16, 19-31.
7. Braasch, E. R., & Demaso, D. R. 1980. Effect of electroconvulsive therapy on serum isoenzymes. Am J Psychiatry, 137, 625-6.
8. Burd, J., & Kettl, P. 1998. Incidence of asystole in electroconvulsive therapy in elderly patients. Am J Geriatr Psychiatry, 6, 203-11.
9. Carroll, B. J. 1986. Informed use of the dexamethasone suppression test. J Clin Psychiatry, 47, 10-2.
10. Coffey, C. E., Lucke, J., Weiner, R. D., Krystal, A. D., & Aque, M. 1995. Seizure threshold in electroconvulsive therapy: I. Initial seizure threshold. Biol Psychiatry, 37, 713-20.
11. Coffey, C. E., Weiner, R. D., Djang, W. T., et al. 1991. Brain anatomic effects of electroconvulsive therapy. A prospective magnetic resonance imaging study. Arch Gen Psychiatry, 48, 1013-21.
12. Dec, G. W., Jr., Stern, T. A., & Welch, C. 1985. The effects of electroconvulsive therapy on serial electrocardiograms and serum cardiac enzyme values. A prospective study of depressed hospitalized inpatients. JAMA, 253, 2525-9.
13. Devanand, D. P. 1995. Does electroconvulsive therapy damage brain cells? Semin Neurol, 15, 351-7.
14. Devanand, D. P., Dwork, A. J., Hutchinson, E. R., Bolwig, T. G., & Sackeim, H. A. 1994. Does ECT alter brain structure? Am J Psychiatry, 151, 957-70.
15. Dong, J., Min, S., Wei, K., et al. 2010. Effects of electroconvulsive therapy and propofol on spatial memory and glutamatergic system in hippocampus of depressed rats. J ECT, 26, 126-30.
16. Dukakis, K., & Tye, L. 2006. Shock: The Healing Power of Electroconvulsive Therapy. New York: Avery.
17. Enev, M., McNally, K. A., Varghese, G., et al. 2007. Imaging onset and propagation of ECT-induced seizures. Epilepsia, 48, 238-44.
18. Esel, E., Kose, K., Hacimusalar, Y., et al. 2008. The effects of electroconvulsive therapy on GABAergic function in major depressive patients. J ECT, 24, 224-8.
19. Fall, P. A., Ekberg, S., Granerus, A. K., & Granerus, G. 2000. ECT in Parkinson's diseasedopamine transporter visualised by [123I]-beta-CIT SPECT. J Neural Transm, 107, 997-1008.
20. Ferraro, T. N., Golden, G. T., & Hare, T. A. 1990. Repeated electroconvulsive shock selectively alters gamma-aminobutyric acid levels in the rat brain: Effect of electrode placement. Convuls Ther, 6, 199-208.
21. Fink, M. 1979. Convulsive Therapy: Theory and Practice. New York: Raven Press.
22. Fink, M. 2009. Electroconvulsive Therapy: A Guide for Professionals and Their Patients. New York: Oxford University Press.
23. Fink, M., Abrams, R., Bailine, S., & Jaffe, R. 1996. Ambulatory electroconvulsive therapy: Report of a task force of the association for convulsive therapy. Association for Convulsive Therapy. Convuls Ther, 12, 42-55.
24. Fink, M., & Nemeroff, C. B. 1989. A Neuroendocrine View of ECT. Convuls Ther, 5, 296-304.
25. Fink, M., & Taylor, M. A. 2006. Catatonia: A Clinician's Guide to Diagnosis and Treatment. Cambridge: Cambridge University Press.
26. Fochtmann, L. J. 1994. Animal studies of electroconvulsive therapy: Foundations for future research. Psychopharmacol Bull, 30, 321-444.
27. Griesemer, D. A., Kellner, C. H., Beale, M. D., & Smith, G. M. 1997. Electroconvulsive therapy for treatment of intractable seizures. Initial findings in two children. Neurology, 49, 1389-92.
28. Heninger, G. R., Delgado, P. L., & Charney, D. S. 1996. The revised monoamine theory of depression: A modulatory role for monoamines, based on new findings from monoamine depletion experiments in humans. Pharmacopsychiatry, 29, 2-11.
29. Hermann, R. C., Dorwart, R. A., Hoover, C. W., & Brody, J. 1995. Variation in ECT use in the United States. Am J Psychiatry, 152, 869-75.
30. Holaday, J. W., Tortella, F. C., Long, J. B., Belenky, G. L., & Hitzemann, R. J. 1986. Endogenous opioids and their receptors. Evidence for involvement in the postictal effects of electroconvulsive shock. Ann N Y Acad Sci, 462, 124-39.
31. Husain, M. M., Rush, A. J., Fink, M., et al. 2004. Speed of response and remission in major depressive disorder with acute electroconvulsive therapy (ECT): A Consortium for Research in ECT (CORE) report. J Clin Psychiatry, 65, 485-91.
32. Jaffe, R., Dubin, W., Shoyer, B., et al. 1990. Outpatient electroconvulsive therapy: Efficacy and safety. Convuls Ther, 6, 231-8.
33. Janicak, P. G., Davis, J. M., Gibbons, R. D., et al. 1985. Efficacy of ECT: A meta-analysis. Am J Psychiatry, 142, 297-302.
34. Kamil, R., & Joffe, R. T. 1991. Neuroendocrine testing in electroconvulsive therapy. Psychiatr Clin North Am, 14, 961-70.
35. Kellner, C. H., Knapp, R. G., Petrides, G., et al. 2006. Continuation electroconvulsive therapy vs pharmacotherapy for relapse prevention in major depression: A multisite study from the Consortium for Research in Electroconvulsive Therapy (CORE). Arch Gen Psychiatry, 63, 1337-44.
36. Krystal, A. D., & Weiner, R. D. 1994. ECT seizure therapeutic adequacy. Convuls Ther, 10, 153-64.
37. Lamont, S. R., Stanwell, B. J., Hill, R., Reid, I. C., & Stewart, C. A. 2005. Ketamine pretreatment dissociates the effects of electroconvulsive stimulation on mossy fibre sprouting and cellular proliferation in the dentate gyrus. Brain Res, 1053, 27-32.
38. Lisanby, S. H. 2007. Electroconvulsive therapy for depression. N Engl JMed, 357, 1939-45.
39. Lisanby, S. H., Bazil, C. W., Resor, S. R., et al. 2001. ECT in the treatment of status epilepticus. J ECT, 17, 210-5.
40. Madsen, T. M., Treschow, A., Bengzon, J., et al. 2000. Increased neurogenesis in a model of electroconvulsive therapy. Biol Psychiatry, 47, 1043-9.
41. Mann, J. J. 1998. Neurobiological correlates of the antidepressant action of electroconvulsive therapy. J ECT, 14, 172-80.
42. Mann, J. J., & Kapur, S. 1992. Clinical studies of adrenergic receptor function in depression: Effect of electroconvulsive therapy. Clin Neuropharmacol. 15, 675A-676A.
43. Messina, A. G., Paranicas, M., Katz, B., et al. 1992. Effect of electroconvulsive therapy on electrocardiogram and echocardiogram. Anesth Analg, 75, 511-4.
44. Newman, M. E., Gur, E., Shapira, B., & Lerer, B. 1998. Neurochemical mechanisms of action of ECS: Evidence from in vivo studies. J ECT, 14, 153-71.
45. Nobler, M. S., Sackeim, H. A., Solomou, M., et al. 1993. EEG manifestations during ECT: Effects of electrode placement and stimulus intensity. Biol Psychiatry, 34, 321-30.
46. Nobler, M. S., Teneback, C. C., Nahas, Z., et al. 2000. Structural and functional neuroimaging of electroconvulsive therapy and transcranial magnetic stimulation. Depress Anxiety, 12, 144-56.
47. Ottosson, J. O. 1960. Effect of lidocaine on the seizure discharge in electroconvulsive therapy. Acta Psychiatr Scand Suppl, 35, 7-32.
48. Ottosson, J. O. 1962. Seizure characteristics and therapeutic efficiency in electroconvulsive therapy: An analysis of the antidepressive efficiency of grand mal and lidocainemodified seizures. J Nerv Ment Dis, 135, 239-51.
49. Petrides, G., Braga, R. J., Fink, M., et al. 2009. Seizure threshold in a large sample: Implications for stimulus dosing strategies in bilateral electroconvulsive therapy: A report from CORE. J ECT, 25, 232-7.
50. Pfleiderer, B., Michael, N., Erfurth, A., et al. 2003. Effective electroconvulsive therapy reverses glutamate/glutamine deficit in the left anterior cingulum of unipolar depressed patients. Psychiatry Res, 122, 185-92.
51. Piccinni, A., Del Debbio, A., Medda, P., et al. 2009. Plasma brain-derived neurotrophic factor in treatment-resistant depressed patients receiving electroconvulsive therapy. Eur Neuropsychopharmacol, 19, 349-55.
52. Popeo, D., & Kellner, C. H. 2009. ECT for Parkinson's disease. Med Hypotheses, 73, 468-9.
53. Rudorfer, M. V., Risby, E. D., Hsiao, J. K., Linnoila, M., & Potter, W. Z. 1988. Disparate biochemical actions of electroconvulsive therapy and antidepressant drugs. Convuls Ther, 4, 133-40.
54. Sackeim, H., Decina, P., Prohovnik, I., & Malitz, S. 1987. Seizure threshold in electroconvulsive therapy. Effects of sex, age, electrode placement, and number of treatments. Arch Gen Psychiatry, 44, 355-60.
55. Sackeim, H. A. 1989. The unique contributions of ECT to understanding the pathophysiology and treatment of affective disorders. Convuls Ther, 5, 207-8.
56. Sackeim, H. A. 1999. The anticonvulsant hypothesis of the mechanisms of action of ECT: Current status. J ECT, 15, 5-26.
57. Sackeim, H. A., Long, J., Luber, B., et al. 1994. Physical properties and quantification of the ECT stimulus: I. Basic principles. Convuls Ther, 10, 93-123.
58. Sackeim, H. A., Luber, B., Katzman, G. P., et al. 1996. The effects of electroconvulsive therapy on quantitative electroencephalograms. Relationship to clinical outcome. Arch Gen Psychiatry, 53, 814-24.
59. Scott, A. I., Douglas, R.H., Whitfield, A., & Kendell, R. E. 1990. Time course of cerebra; magnetic resonance changes after electroconvulsive therapy. Br J Psychiatry, 156, 551-3.
60. Shorter, E., & Healy, D. 2007. Shock Therapy: A History of Electroconvulsive Treatment in Mental Illness. New Brunswick, NJ: Rutgers University Press.
61. Sienaert, P., Vansteelandt, K., Demyttenaere, K., & Peuskens, J. 2009. Randomized comparison of ultra-brief bifrontal and unilateral electroconvulsive therapy for major depression: Clinical efficacy. J Affect Disord, 116, 106-12.
62. Sienaert, P., Vansteelandt, K., Demyttenaere, K., & Peuskens, J. 2010. Randomized comparison of ultra-brief bifrontal and unilateral electroconvulsive therapy for major depression: Cognitive side-effects. J Affect Disord, 122, 60-7.
63. Staton, R. D., Hass, P. J., & Brumback, R.A. 1981. Electroencephalographic recording during bitemporal and unilateral non-dominant hemisphere (Lancaster Position) electroconvulsive therapy. J Clin Psychiatry, 42, 264-9.
64. Swartz, C. M. 2009. Electroconvulsive and Neuromodulation Therapies. Cambridge: Cambridge University Press.
65. Thompson, J. W., Weiner, R. D., & Myers, C. P. 1994. Use of ECT in the United States in 1975, 1980, and 1986. Am J Psychiatry, 151, 1657-61.
66. Weiner, R. D., Coffey, C. E., & Krystal, A. D. 1991. The monitoring and management of electrically induced seizures. Psychiatr Clin North Am, 14, 845-69.
67. Welch, C. A., & Drop, L. J. 1989. Cardiovascular effects of ECT. Convuls Ther, 5, 35-43.
68. Yatham, L. N., Liddle, P. F., Lam, R. W., et al. 2010. Effect of electroconvulsive therapy on brain 5-HT(2) receptors in major depression. Br J Psychiatry, 196, 474-9.
69. Abrams, R. 1989. ECT in the high-risk patient. Convuls Ther, 5, 1-2.
70. Abrams, R. 2002. Electroconvulsive Therapy. New York: Oxford University Press.
71. Alexopoulus, G. S., Young, R. C., & Abrams, R. C. 1989. ECT in the high-risk geriatric patient. Convuls Ther, 5, 75-87.
72. American Psychiatric Association. 2001. Task Force on Electroconvulsive Therapy. The Practice of Electroconvulsive Therapy: Recommendations for Treatment, Training, and Privileging. Washington, DC: American Psychiatric Association.
73. Andersen, K., Balldin, J. Gottfries, C. G., et al. 1987. A double-blind evaluation of electroconvulsive therapy in Parkinson's disease with "on-off" phenomena. Acta Neurol Scand, 76, 191-9.
74. Anderson, E. L., & Reti, I. M. 2009. ECT in pregnancy: A review of the literature from 1941 to 2007. Psychosom Med, 71, 235-42.
75. Beck, A. T., Ward, C. H., Mendelson, M., Mock, J., & Erbaugh, J. 1961. An inventory for measuring depression. Arch Gen Psychiatry, 4, 561-71.
76. Bolwig, T. G. Hertz, M. M., Paulson, O. B., Spotoft, H., & Rafaelsen, O. J. 1977. The permeability of the blood-brain barrier during electrically induced seizures in man. Eur J Clin Invest, 7, 87-93.
77. Brown, G. L., &Wilson, W. P. 1972. Parkinsonism and depression. South Med J, 65, 540-5.
78. Brown, W. A. 2007. Treatment response in melancholia. Acta Psychiatr Scand Suppl, 125-9.
79. Burgut, F. T., Popeo, D., & Kellner, C. H. 2010. ECT for agitation in dementia: Is it appropriate? Med Hypotheses, 75, 5-6.
80. Carroll, B. J., Feinberg, M., Smouse, P. E., Rawson, S. G., & Greden, J. F. 1981. The Carroll rating scale for depression. I. Development, reliability and validation. Br J Psychiatry, 138, 194-200.
81. Cline, J. S., & Roos, K. 2007. Treatment of status epilepticus with electroconvulsive therapy. J ECT, 23, 30-2.
82. Coffey, C. E. 1993. The Clinical Science of Electroconvulsive Therapy. Washington, DC: American Psychiatric Press.
83. Coffey, C. E., Lucke, J., Weiner, R. D., Krystal, A. D., & Aque, M. 1995. Seizure threshold in electroconvulsive therapy: I. Initial seizure threshold. Biol Psychiatry, 37, 713-20.
84. Davis, J. M., Janicak, P. G., Sakkas, P., Gilmore, C., & Wang, Z. 1991. Electroconvulsive therapy in the treatment of the neuroleptic malignant syndrome. Convuls Ther, 7, 111-20.
85. Dolenc, T. J., Habl, S. S., Barnes, R. D., & Rasmussen, K. G. 2004. Electroconvulsive therapy in patients taking monoamine oxidase inhibitors. J ECT, 20, 258-61.
86. Dolenc, T. J., & Rasmussen, K. G. 2005. The safety of electroconvulsive therapy and lithium in combination: A case series and review of the literature. J ECT, 21, 165-70.
87. Dubovsky, S. L. 1986. Using electroconvulsive therapy for patients with neurological disease. Hosp Community Psychiatry, 37, 819-25.
88. el-Ganzouri, A. R., Ivankovich, A. D., Braverman, B., & McCarthy, R. 1985. Monoamine oxidase inhibitors: Should they be discontinued preoperatively? Anesth Analg, 64, 592-6.
89. Farah, A., Belae, M. D., & Kellner, C. H. 1995. Risperidone and ECT combination therapy: A case series. Convuls Ther, 11, 280-2.
90. Figiel, G. S., Hassen, M. A., Zorumski, C., et al. 1991. ECT-induced delirium in depressed patients with Parkinson's disease. J Neuropsychiatry Clin Neurosci, 3, 405-11.
91. Fink, M. 1994. Indications for the use of ECT. Psychopharmacol Bull, 30, 269-75; discussion 276-80.
92. Fink, M., & Taylor, M. A. 2006. Catatonia: A Clinician's Guide to Diagnosis and Treatment. Cambridge: Cambridge University Press.
93. Fochtmann, L. 1988. A mechanism for the efficacy of ECT in Parkinson's disease. Convuls Ther, 4, 321-7.
94. Folstein, M. F., Folstein, S. E., & McHugh, P. R. 1975. "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res, 12, 189-98.
95. Goldstein, M. Z., & Richardson, C. 1988. Meningioma with depression: ECT risk or benefit? Psychosomatics, 29, 349-51.
96. Griesemer, D. A., Kellner, C. H., Beale, M. D., & Smith, G. M. 1997. Electroconvulsive therapy for treatment of intractable seizures. Initial findings in two children. Neurology, 49, 1389-92.
97. Grinspoon, L., & Greenblatt, M. 1963. Pharmacotherapy combined with other treatment methods. Compr Psychiatry, 18, 256-62.
98. Hamilton, M. 1960. A rating scale for depression. J Neurol Neurosurg Psychiatry, 23, 56-62.
99. Haskett, R.F., & Loo, C. 2010. Adjunctive psychotropic medications during electroconvulsive therapy in the treatment of depression, mania, and schizophrenia. J ECT, 26, 196-201.
100. Hausner, L., Damian, M., Sartorius, A., & Frolich, L. 2011. Efficacy and cognitive side effects of electroconvulsive therapy (ECT) in depressed elderly inpatients with coexisting mild cognitive impairment or dementia. J Clin Psychiatry, 72, 91-7.
101. Horn, P. J., Reti, I., & Jayaram, G. 2010. Transdermal selegiline in patients receiving electroconvulsive therapy. Psychosomatics, 51, 176-8.
102. Husain, M. M., Rush, A. J., Fink, M., et al. 2004. Speed of response and remission in major depressive disorder with acute electroconvulsive therapy (ECT): A consortium for research in ECT (CORE) report. J Clin Psychiatry, 65, 485-91.
103. Jenkins, L. C., & Graves, H. B. 1965. Potential hazards of psychoactive drugs in association with anaesthesia. Can Anaesth Soc J, 12, 121-8.
104. Kamel, H., Cornes, S. B., Hedge, M., Hall, S. E., & Josephson, S. A. 2010. Electroconvulsive therapy for refractory status epilepticus: A case series. Neurocritical Care, 12, 204-10.
105. Kellner, C. H. 1995. Is ECT the treatment of choice for first-break psychosis? Convuls Ther, 11, 155-7.
106. Kellner, C. H., Beale, M. D., Pritchett, J. T., Bernstein, H. J., & Burns, C. M. 1994. Electroconvulsive therapy and Parkinson's disease: The case for further study. Psychopharmacol Bull, 30, 495-500.
107. Kellner, C. H., Burns, C. M., Bernstein, H. J., Monroe, R. R., Jr., & George, M. S. 1991a. Safe administration of ECT in a patient with a calcified frontal mass. J Neuropsychiatry Clin Neurosci, 3, 353-4.
108. Kellner, C.H., Nixon, D.W., & Bernstein, H.J. 1991b. ECT-drug interactions: A review. Psychopharmacol Bull, 27, 595-609.
109. Kellner, C. H., Knapp, R., Husain, M. M., et al. 2010. Bifrontal, bitemporal and right unilateral electrode placement in ECT: Randomised trial. Br J Psychiatry, 196, 226-34.
110. Kellner, C. H., Knapp, R. G., Petrides, G., et al. 2006. Continuation electroconvulsive therapy vs pharmacotherapy for relapse prevention in major depression: A multisite study from the Consortium for Research in Electroconvulsive Therapy (CORE). Arch Gen Psychiatry, 63, 1337-44.
111. Kessing, L., Labianca, J. H., & Bolwig, T. G. 1994. HIV-induced stupor treated with ECT. Convuls Ther, 10, 232-5.
112. Klapheke, M. M. 1993. Combining ECT and antipsychotic agents: Benefits and risks. Convuls Ther, 9, 241-55.
113. Lauritzen, L., Odgaard, K., Clemmesen, L., et al. 1996. Relapse prevention by means of paroxetine in ECT-treated patients with major depression: A comparison with imipramine and placebo in medium-term continuation therapy. Acta psychiatrica Scandinavica, 94, 241-51.
114. Lee, K. 2006. Acute embolic stroke after electroconvulsive therapy. J ECT, 22, 67-9.
115. Lisanby, S. H., Sampson, S., Husain, M. M., et al. 2008. Toward individualized postelectroconvulsive therapy care: Piloting the Symptom-Titrated, Algorithm-Based Longitudinal ECT (STABLE) intervention. J ECT, 24, 179-82.
116. Maltbie, A. A., Wingfield, M. S., Volow, M. R., et al. 1980. Electroconvulsive therapy in the presence of brain tumor. Case reports and an evaluation of risk. J Nerv Ment Dis, 168, 400-5.
117. Masdrakis, V. G., Tzanoulinos, G., Markatou, M., & Oulis, P. 2011. Cardiac safety of the electroconvulsive therapy-paliperidone combination: A preliminary study. Gen Hosp Psychiatry, 33, 83 e9-10.
118. McKinney, P. A., Beale, M. D., & Kellner, C. H. 1998. Electroconvulsive therapy in a patient with a cerebellar meningioma. J ECT, 14, 49-52.
119. Mehta, V., Mueller, P. S., Gonzalez-Arriaza, H. L., Pankatraz, V. S., & Rummans, T. A. 2004. Safety of electroconvulsive therapy in patients receiving long-term warfarin therapy. Mayo Clinic proceedings. 79, 1396-401.
120. Montgomery, S. A., & Asberg, M. 1979. A new depression scale designed to be sensitive to change. Br J Psychiatry, 134, 382-9.
121. Mukherjee, S., Sackeim, H. A., & Schnur, D. B. 1994. Electroconvulsive therapy of acute manic episodes: A review of 50 years' experience. Am J Psychiatry, 151, 169-76.
122. Petrides, G., & Fink, M. 1996. Atrial fibrillation, anticoagulation, and electroconvulsive therapy. Convuls Ther, 12, 91-8.
123. Pettinati, H. M., Stephens, S. M., Willis, K. M., & Robin, S. E. 1990. Evidence for less improvement in depression in patients taking benzodiazepines during unilateral ECT. Am J Psych, 147, 1029-35.
124. Popeo, D., & Kellner, C. H. 2009. ECT for Parkinson's disease. Med Hypotheses, 73, 468-9.
125. Pritchett, J. T., Bernstein, H. J., & Kellner, C. H. 1993. Combined ECT and antidepressant drug therapy. Convuls Ther, 9, 256-61.
126. Raskin, D. E. 1984. Cardiac irritability, tricyclic antidepressants, and electroconvulsive therapy. J Clin Psychopharmacology, 4, 237-8.
127. Rasmussen, K., & Abrams, R. 1991. Treatment of Parkinson's disease with electroconvulsive therapy. Psychiatr Clin North Am, 14, 925-33.
128. Rasmussen, K. G., Ryan, D. A., & Mueller, P. S. 2006. Blood glucose before and after ECT treatments in Type 2 diabetic patients. J ECT, 22, 124-6.
129. Rasmussen, K. G., & Zorumski, C. F. 1993. Electroconvulsive therapy in patients taking theophylline. J Clin Psychiatry, 54, 427-31.
130. Rubner, P., Koppi, S., & Conco, A. 2009. Frequency of and rationales for the combined use of electroconvulsive therapy and antiepileptic drugs in Austria and the literature. World J Biol Psychiatry, 10, 836-45.
131. Rush, A. J., Trivedi, M. H., Ibrahim, H. M., et al. 2003. The 16-Item Quick Inventory of Depressive Symptomatology (QIDS), clinician rating (QIDS-C), and self-report (QIDS-SR): A psychometric evaluation in patients with chronic major depression. Biol Psychiatry, 54, 573-83.
132. Sackeim, H. A., Decina, P., Prohovnik, I., Malitz, S., & Resor, S. R. 1983. Anticonvulsant and antidepressant properties of electroconvulsive therapy: A proposed mechanism of action. Biolo psychiatry, 18, 1301-10.
133. Sackeim, H. A., Dillingham, E. M., Prudic, J., et al. 2009. Effect of concomitant pharmacotherapy on electroconvulsive therapy outcomes: Short-term efficacy and adverse effects. Arch Gen Psychiatry, 66, 729-37.
134. Schaerf, F. W., Miller, R. R., Lipsey, J. R., & McPherson, R. W. 1989. ECT for major depression in four patients infected with human immunodeficiency virus. Am J Psychiatry, 146, 782-4.
135. Schak, K. M., Mueller, P. S., Barnes, R. D., & Rasmussen, K. G. 2008. The safety of ECT in patients with chronic obstructive pulmonary disease. Psychosomatics, 49, 208-11.
136. Schnur, D. B., Mukherjee, S., Silver, J., Degreef, G., & Lee, C. 1989. Electroconvulsive therapy in the treatment of episodic aggressive dyscontrol in psychotic patients. Convuls Ther, 5, 353-61.
137. Sienaert, P., & Peuskens, J. 2007. Anticonvulsants during electroconvulsive therapy: Review and recommendations. J ECT, 23, 120-3.
138. Small, J. G., Klapper, M.H., Kellams, J. J., et al. 1988. Electroconvulsive treatment compared with lithium in the management of manic states. Arch Gen Psychiatry, 45, 727-32.
139. Steingard, R., Khan, A., Gonzalez, A., & Herzog, D. B. 1992. Neuroleptic malignant syndrome: Review of experience with children and adolescents. J Child Adolesc Psychopharmacol, 2, 183-98.
140. Stromgren, L. S. 1997. ECT in acute delirium and related clinical states. Convuls Ther, 13, 10-7.
141. Stromgren, L. S., Dahl, J., Fjeldborg, N., & Thomsen, A. 1980. Factors influencing seizure duration and number of seizures applied in unilateral electroconvulsive therapy. Anaesthetics and benzodiazepines. Acta psychiatrica Scandinavica, 62, 158-65.
142. Tancer, M. E., & Evans, D. L. 1989. Electroconvulsive Therapy in Geriatric Patients Undergoing Anticoagulation Therapy. Convuls Ther, 5, 102-9.
143. Tess, A. V., & Smetana, G. W. 2009. Medical evaluation of patients undergoing electroconvulsive therapy. N Engl J Med, 360, 1437-44.
144. Trollor, J. N., & Sachdev, P. S. 1999. Electroconvulsive treatment of neuroleptic malignant syndrome: A review and report of cases. Australian and New Zealand J psychiatry, 33, 650-9.
145. van den Broek, W. W., Birkenhäger, T. K., Mulder, P. G., Bruijn, J. A., & Moleman, P. 2006. Imipramine is effective in preventing relapse in electroconvulsive therapyresponsive depressed inpatients with prior pharmacotherapy treatment failure: A randomized, placebo-controlled trial. J Clin Psychiatry, 67, 263-8.
146. Virupaksha, H. S., Shashidhara, B., Thirthalli, J., Kumar, C. N., & Gangadhar, B. N. 2010. Comparison of electroconvulsive therapy (ECT) with or without anti-epileptic drugs in bipolar disorder. J Affect Disord, 127, 66-70.
147. Weiner, R. D., Whanger, A. D., Erwin, C. W., & Wilson, W. P. 1980. Prolonged confusional state and EEG seizure activity following concurrent ECT and lithium use. Am J Psychiatry, 137, 1452-3.
148. Zielinski, R. J., Roose, S. P., Devanand, D. P., Woodring, S., & Sackeim, H. A. 1993. Cardiovascular complications of ECT in depressed patients with cardiac disease. Am J Psychiatry, 150, 904-9.
149. Abrams, R. 2002. Electroconvulsive Therapy. New York: Oxford University Press.
150. Abrams, R. & Swartz, C. M. 2009. Thymatron System IV Instruction Manual, Fourteenth Edition, July 2009. Somatics, LLC.
151. Abrams, R., Swartz, C. M., & Vedak, C. 1991. Antidepressant effects of high-dose right unilateral electroconvulsive therapy. Arch Gen Psychiatry, 48, 746-8.
152. American Psychiatric Association. 2001. Task Force on Electroconvulsive Therapy. The Practice of Electroconvulsive Therapy: Recommendations for Treatment, Training, and Privileging. Washington, DC: American Psychiatric Association.
153. Bailine, S. H., Petrides, G., Doft, M., & Lui, G. 2003. Indications for the use of propofol in electroconvulsive therapy. J ECT, 19, 129-32.
154. Bailine, S. H., Rifkin, A., Kayne, E., et al. 2000. Comparison of bifrontal and bitemporal ECT for major depression. Am J Psychiatry, 157, 121-3.
155. Beale, M. D., Kellner, C. H., Lemert, R., et al. 1994a. Skeletal muscle relaxation in patients undergoing electroconvulsive therapy. Anesthesiology, 80, 957.
156. Beale, M. D., Kellner, C. H., Pritchett, J. T., et al. 1994b. Stimulus dose-titration in ECT: A 2-year clinical experience. Convuls Ther, 10, 171-6.
157. Berman, R. M., Cappiello, A., Anand, A., et al. 2000. Antidepressant effects of ketamine in depressed patients. Biol Psychiatry, 47, 351-4.
158. Bryden, M. P. 1982. Laterality: Functional Asymmetry in the Intact Brain. New York: Academic Press.
159. Coffey, C. E., Lucke, J., Weiner, R. D., Krystal, A. D., & Aque, M. 1995. Seizure threshold in electroconvulsive therapy: I. Initial seizure threshold. Biol Psychiatry, 37, 713-20.
160. Coffey, C. E., Weiner, R. D., Hinkle, P. E., et al. 1987. Augmentation of ECT seizures with caffeine. Biol Psychiatry, 22, 637-49.
161. d'Elia, G. 1970. Unilateral electroconvulsive therapy. Acta Psychiatr Scand Suppl, 215, 1-98.
162. Hamilton, M. 1960. A rating scale for depression. J Neurol Neurosurg Psychiatry, 23, 56-62.
163. Howsepian, A. A. 2011. On describing "seizure length" in electroconvulsive therapy. J ECT, 27, 93-4; author reply 94.
164. Kellner, C. H. 2011. Muscle relaxation in electroconvulsive therapy. J ECT, 27, 93; author reply 93.
165. Kellner, C. H., Knapp, R., Husain, M. M., et al. 2010a. Bifrontal, bitemporal and right unilateral electrode placement in ECT: Randomised trial. Br J Psychiatry, 196, 226-34.
166. Kellner, C. H., Tobias, K. G., & Wiegand, J. 2010b. Electrode placement in electroconvulsive therapy (ECT): A review of the literature. J ECT, 26, 175-80.
167. Lapidus, K. A., & Kellner, C. H. 2011. When to switch from unilateral to bilateral electroconvulsive therapy. J ECT, 27, 244-6.
168. Letemendia, F. J., Delva, N. J., Rodenburg, M., et al. 1993. Therapeutic advantage of bifrontal electrode placement in ECT. Psychol Med, 23, 349-60.
169. McCall, W. V., Reid, S., Rosenquist, P., Foreman, A., & Kiesow-Webb, N. 1993. A reappraisal of the role of caffeine in ECT. Am J Psychiatry, 150, 1543-5.
170. Okamoto, N., Nakai, T., Sakamoto, K., et al. 2010. Rapid antidepressant effect of ketamine anesthesia during electroconvulsive therapy of treatment-resistant depression: Comparing ketamine and propofol anesthesia. J ECT, 26, 223-7.
171. Petrides, G., Braga, R. J., Fink, M., et al. 2009. Seizure threshold in a large sample: Implications for stimulus dosing strategies in bilateral electroconvulsive therapy: A report from CORE. J ECT, 25, 232-7.
172. Petrides, G., & Fink, M. 1996. The "half-age" stimulation strategy for ECT dosing. Convuls Ther, 12, 138-46.
173. Pitts, F. N., Desmarais, G. M., Stewart, W., & Schaberg, K. 1965. Induction of anesthesia with methohexital and thiopental in electroconvulsive therapy. The effect on the electrocardiogram and clinical observations in 500 consecutive treatments with each agent. N Engl J Med 273, 353-60.
174. Pratt, R. T., Warrington, E. K., & Halliday, A. M. 1971. Unilateral ECT as a test for cerebral dominance, with a strategy for treating left-handers. Br J Psychiatry, 119, 79-83.
175. Rasmussen, K. G., Jarvis, M. R., & Zorumski, C. F. 1996. Ketamine anesthesia in electroconvulsive therapy. Convuls Ther, 12, 217-23.
176. Sackeim, H. A., Dillingham, E. M., Prudic, J., et al. 2009. Effect of concomitant pharmacotherapy on electroconvulsive therapy outcomes: Short-term efficacy and adverse effects. Arch Gen Psychiatry, 66, 729-37.
177. Sackeim, H. A., Long, J., Luber, B., et al. 1994. Physical properties and quantification of the ECT stimulus: I. Basic principles. Convuls Ther, 10, 93-123.
178. Sackeim, H. A., Prudic, J., Devanand, D. P., et al. 1993. Effects of stimulus intensity and electrode placement on the efficacy and cognitive effects of electroconvulsive therapy. N Engl J Med, 328, 839-46.
179. Sackeim, H. A., Prudic, J., Nobler, M. S., et al. 2008. Effects of pulse width and electrode placement on the efficacy and cognitive effects of electroconvulsive therapy. Brain Stimul, 1, 71-83.
180. Sienaert, P., Vansteelandt, K., Demyttenaere, K., & Peuskens, J. 2009. Randomized comparison of ultra-brief bifrontal and unilateral electroconvulsive therapy for major depression: Clinical efficacy. J Affect Disord, 116, 106-12.
181. Sienaert, P., Vansteelandt, K., Demyttenaere, K., & Peuskens, J. 2010. Randomized comparison of ultra-brief bifrontal and unilateral electroconvulsive therapy for major depression: Cognitive side-effects. J Affect Disord, 122, 60-7.
182. Small, J. G., Small, I. F., Milstein, V., Kellams, J. J., Klapper, M. H. 1985. Manic symptoms: An indication for bilateral ECT. Biol Psychiatry, 20, 125-34.
183. Wajima, Z., Yoshikawa, T., Ogura, A., et al. 2001. The effects of diltiazem on hemodynamics and seizure duration during electroconvulsive therapy. Anesth Analg, 92, 1327-30.
184. Wajima, Z., Yoshikawa, T., Ogura, A., et al. 2002. Intravenous verapamil blunts hyperdynamic responses during electroconvulsive therapy without altering seizure activity. Anesth Analg, 95, 400-2, table of contents.
185. Zhang, Y., White, P. F., Thornton, L., Perdue, L., Downing, M. 2005. The use of nicardipine for electroconvulsive therapy: A dose-ranging study. Anesth Analg, 100, 378-81.
186. Abrams, R. 1967. Daily administration of unilateral ECT. Am J Psychiatry, 124, 384-6.
187. Bailine, S., Fink, M., Knapp, R., et al. 2010. Electroconvulsive therapy is equally effective in unipolar and bipolar depression. Acta Psychiatr Scand, 121, 431-6.
188. Fink, M., Abrams, R., Bailine, S., & Jaffe, R. 1996. Ambulatory electroconvulsive therapy: Report of a task force of the association for convulsive therapy. Association for Convulsive Therapy. Convuls Ther, 12, 42-55.
189. Folstein, M. F., Folstein, S. E., & McHugh, P. R. 1975. "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatric Res, 12, 189-98.
190. Frank, E., Kupper, D. J., Perel, J. M., et al. 1990. Three-year outcomes for maintenance therapies in recurrent depression. Arch Gen Psychiatry, 47, 1093-9.
191. Hamilton, M. 1960. A rating scale for depression. J Neurol Neurosurg Psychiatry, 23, 56-62.
192. Kellner, C. H., Burns, C. M., Bernstein, H. J., & Monroe, R. R., Jr. 1991. Electrode placement in maintenance electroconvulsive therapy. Convuls Ther, 7, 61-2.
193. Kellner, C. H., Knapp, R. G., Petrides, G., et al. 2006. Continuation electroconvulsive therapy vs pharmacotherapy for relapse prevention in major depression: A multisite study from the Consortium for Research in Electroconvulsive Therapy (CORE). Arch Gen Psychiatry, 63, 1337-44.
194. Kobeissi, J., Aloysi, A., Tobias, K., Popeo, D., & Kellner, C. H. 2011. Resolution of severe suicidality with a single electroconvulsive therapy. J ECT, 27, 86-8.
195. Lerer, B., Shapira, B., Calev, A., et al. 1995. Antidepressant and cognitive effects of twiceversus three-times-weekly ECT. Am J Psychiatry, 152, 564-70.
196. Lisanby, S. H., Sampson, S., Husain, M. M., et al. 2008. Toward individualized postelectroconvulsive therapy care: Piloting the Symptom-Titrated, Algorithm-Based Longitudinal ECT (STABLE) intervention. J ECT, 24, 179-82.
197. Monroe, R. R., Jr. 1991. Maintenance electroconvulsive therapy. Psychiatr Clin North Am, 14, 947-60.
198. Nasreddine, Z. S., Phillips, N. A., Bedirian, V., et al. 2005. The Montreal Cognitive Assessment, MoCA: A brief screening tool for mild cognitive impairment. J Am Geriatrics Soc, 53, 695-9.
199. Petrides, G., Dhossche, D., Fink, M., & Francis, A. 1994. Continuation ECT: Relapse prevention in affective disorders. Convuls Ther, 10, 189-94.
200. Sackeim, H. A., Haskett, R. F., Mulsant, B. H., et al. 2001. Continuation pharmacotherapy in the prevention of relapse following electroconvulsive therapy: A randomized controlled trial. JAMA, 285, 1299-307.
201. Sackeim, H. A., Prudic, J., Devanand, D. P., et al. 1990. The impact of medication resistance and continuation pharmacotherapy on relapse following response to electroconvulsive therapy in major depression. J Clin Psychopharmacol, 10, 96-104.
202. Sienaert, P., Vansteelandt, K., Demyttenaere, K., & Peuskens, J. 2009. Ultra-brief pulse ECT in bipolar and unipolar depressive disorder: Differences in speed of response. Bipolar Disord, 11, 418-24.
203. Stromgren, L. S. 1990. Frequency of ECT treatments. Convuls Ther, 6, 317-8.
204. Thomas, S. G., & Kellner, C. H. 2003. Remission of major depression and obsessivecompulsive disorder after a single unilateral ECT. J ECT, 19, 50-1.
205. Abrams, R. 2002. Electroconvulsive Therapy. New York: Oxford University Press.
206. Donahue, A. B. 2000. Electroconvulsive therapy and memory loss: A personal journey. J ECT, 16, 133-43.
207. Loo, C. 2008. Cognitive outcomes in electroconvulsive therapy: Optimizing current clinical practice and researching future strategies. J ECT, 24, 1-2.
208. Markowitz, J. S., Kellner, C. H., Devane, C. L., et al. 2001. Intranasal sumatriptan in post- ECT headache: Results of an open-label trial. J ECT, 17, 280-3.
209. Semkovska, M., & McLoughlin, D. M. 2010. Objective cognitive performance associated with electroconvulsive therapy for depression: A systematic review and metaanalysis. Biol Psychiatry, 68, 568-77.
210. Squire, L. R. 1986. Memory functions as affected by electroconvulsive therapy. Ann N Y Acad Sci, 462, 307-14.
211. American Psychiatric Association. 2001. Task Force on Electroconvulsive Therapy. The Practice of Electroconvulsive Therapy: Recommendations for Treatment, Training, and Privileging. Washington, DC: American Psychiatric Association.
212. Abrams, R. 2002. Electroconvulsive Therapy. Oxford, New York: Oxford University Press.
213. Fink, M. 2011. Electroconvulsive therapy resurrected: Its successes and promises after 75 years. Canad J Psychiatry. Revue canadienne de psychiatrie, 56, 3-4.
214. Hersh, J. 2011. Struck by Living: From Depression to Hope. Austin, TX, Greenleaf Book Group Press.
215. Loo, C. K., Schweitzer, I., & Pratt, C. 2006. Recent advances in optimizing electroconvulsive therapy. The Australian and New Zealand J Psychiatry, 40, 632-8.
216. Manning, M. 1994. Undercurrents: A Therapist's Reckoning With Her Own Depression. New York: HarperCollins Pub.
217. Sienaert, P. 2011. What we have learned about electroconvulsive therapy and its relevance for the practising psychiatrist. Canadian J Psychiatry. Revue Canadienne de Psychiatrie, 56, 5-12.
218. Abelson, J. L., Curtis, G. C., Sagher, O., et al. 2005. Deep brain stimulation for refractory obsessive-compulsive disorder. Biol Psychiatry, 57, 510-6.
219. Boviatsis, E. J., Stavrinou, L. C., Themistocleous, M., Kouyialis, A. T., & Sakas, D. E. 2010. Surgical and hardware complications of deep brain stimulation. A seven-year experience and review of the literature. Acta Neurochir (Wien), 152, 2053-62.
220. Bronstein, J. M., Tagliati, M., Alterman, R. L., et al. 2011. Deep brain stimulation for Parkinson disease: An expert consensus and review of key issues. Arch Neurol, 68, 165.
221. Chang, C. H., Chen, S. Y., Hsiao, Y. L., Tsai, S. T., & Tsai, H. C. 2010. Hypomania with hypersexuality following bilateral anterior limb stimulation in obsessive-compulsive disorder. J Neurosurg, 112, 1299-300.
222. de Koning, P. P., Figee, M., van den Munckhof, P., Schuurman, P. R., & Denys, D. 2011. Current status of deep brain stimulation for obsessive-compulsive disorder: A clinical review of different targets. Curr Psychiatry Rep, 13, 274-82.
223. Denys, D., Mantione, M., Figee, M., et al. 2010. Deep brain stimulation of the nucleus accumbens for treatment-refractory obsessive-compulsive disorder. Arch Gen Psychiatry, 67, 1061-8.
224. DiLorenzo, D. J., Jankovic, J., Simpson, R. K., Takei, H., & Powell, S. Z. 2010. Long-term deep brain stimulation for essential tremor: 12-year clinicopathologic follow-up. Mov Disord, 25, 232-8.
225. Doshi, P. K. 2011. Long-term surgical and hardware-related complications of deep brain stimulation. Stereotact Funct Neurosurg, 89, 89-95.
226. Dougherty, D. D., Baer, L., Cosgrove, G. R., et al. 2002. Prospective long-term follow-up of 44 patients who received cingulotomy for treatment-refractory obsessivecompulsive disorder. Am J Psychiatry, 159, 269-75.
227. Fins, J. J., Mayberg, H. S., Nuttin, B., et al. 2011. Misuse of the FDA's humanitarian device exemption in deep brain stimulation for obsessive-compulsive disorder. Health Aff (Millwood). 30, 302-11.
228. Follett, K. A., Weaver, F. M., Stern, M., et al. 2010. Pallidal versus subthalamic deep-brain stimulation for Parkinson's disease. N Engl J Med, 362, 2077-91.
229. Foltynie, T., & Hariz, M. I. 2010. Surgical management of Parkinson's disease. Expert Rev Neurother, 10, 903-14.
230. Gologorsky, Y., Ben-Haim, S., Moshier, E. L., et al. 2011. Transgressing the ventricular wall during subthalamic deep brain stimulation surgery for Parkinson disease increases the risk of adverse neurological sequelae. Neurosurgery, 69, 294-9; discussion 9-300.
231. Goodman, W. G., & Alterman, R. Inactivation of deep brain stimulation during sleep in four patients with obsessive-compulsive disorder. unpublished data. 2011.
232. Goodman, W. K., & Alterman R. L. 2012. Deep brain stimulation for intractable psychiatric disorders. Annu Rev Med, 63, 1-14.
233. Goodman, W. K., Foote, K. D., Greenberg, B. D., et al. 2010. Deep brain stimulation for intractable obsessive compulsive disorder: Pilot study using a blinded, staggeredonset design. Biol Psychiatry, 67, 535-42.
234. Goodman, W. K., & Insel, T. R. 2009. Deep brain stimulation in psychiatry: Concentrating on the road ahead. Biol Psychiatry, 65, 263-6.
235. Greenberg, B. D., Askland, K. D., & Carpenter, L. L. 2008. The evolution of deep brain stimulation for neuropsychiatric disorders. Front Biosci, 13, 4638-48.
236. Greenberg, B. D., Gabriels, L. A., Malone, D. A., Jr., et al. 2010a. Deep brain stimulation of the ventral internal capsule/ventral striatum for obsessive-compulsive disorder: Worldwide experience. Mol Psychiatry, 15, 64-79.
237. Greenberg, B. D., Rauch, S. L., & Haber, S. N. 2010b. Invasive circuitry-based neurotherapeutics: Stereotactic ablation and deep brain stimulation for OCD. Neuropsychopharmacology, 35, 317-36.
238. Huff, W., Lenartz, D., Schormann, M., et al. 2010. Unilateral deep brain stimulation of the nucleus accumbens in patients with treatment-resistant obsessive-compulsive disorder: Outcomes after one year. Clin Neurol Neurosurg, 112, 137-43.
239. Kennedy, S. H., Giacobbe, P., Rizvi, S. J., et al. 2011. Deep brain stimulation for treatmentresistant depression: Follow-up after 3 to 6 years. Am J Psychiatry, 168, 502-10.
240. Mallet, L., Polosan, M., Jaafari, N., et al. 2008. Subthalamic nucleus stimulation in severe obsessive-compulsive disorder. N Engl J Med. 359, 2121-34.
241. Malone, D. A., Jr., Dougherty, D. D., Rezai, A. R., et al. 2009. Deep brain stimulation of the ventral capsule/ventral striatum for treatment-resistant depression. Biol Psychiatry, 65, 267-75.
242. McNeely, H. E., Mayberg, H. S., Lozano, A. M., & Kennedy, S. H. 2008. Neuropsychological impact of Cg25 deep brain stimulation for treatment-resistant depression: Preliminary results over 12 months. J Nerv Ment Dis. 196, 405-10.
243. Mikos, A., Pavon, J., Bowers, D., et al. 2010. Factors related to extended hospital stays following deep brain stimulation for Parkinson's disease. Parkinsonism Relat Disord, 16, 324-8.
244. Mindus, P., Edman, G., & Andréewitch, S. 1999. A prospective, long-term study of personality traits in patients with intractable obsessional illness treated by capsulotomy. Acta Psychiatr Scand, 99, 40-50.
245. Nuttin, B., Cosyns, P., Demeulemeester, H., Gybels, J., & Meyerson, B. 1999. Electrical stimulation in anterior limbs of internal capsules in patients with obsessivecompulsive disorder. Lancet, 354, 1526.
246. Oh, M. Y., Abosch, A., Kim, S. H., Lang, A. E., & Lozano, A. M. 2002. Long-term hardware-related complications of deep brain stimulation. Neurosurgery, 50, 1268-74; discussion 74-6.
247. Okun, M. S., Bowers, D., Springer, U., Shapira, N. A., Malone, D., Rezai, A. R., Nuttin, B., Heilman, K. M. Morecraft, R. J., Rasmussen, S. A., Greenberg, B. D., Foote, K. D., & Goodman, W. K. 2004. What's in a "smile?" Intra-operative observations of contralateral smiles induced by deep brain stimulation. Neurocase, 10, 271-9.
248. Paluzzi, A., Belli, A., Bain, P., Liu, X., & Aziz, T. M. 2006. Operative and hardware complications of deep brain stimulation for movement disorders. Br J Neurosurg, 20, 290-5.
249. Sansur, C. A., Frysinger, R. C., Pouratian, N., et al. 2007. Incidence of symptomatic hemorrhage after stereotactic electrode placement. J Neurosurg, 107, 998-1003.
250. Shapira, N. A., Okun, M. S., Wint, D., et al. 2006. Panic and fear induced by deep brain stimulation. J Neurol Neurosurg Psychiatry, 77, 410-2.
251. Aleman, A., Sommer, I., & Kahn, R. 2007. Efficacy of slow repetitive transcranial magnetic stimulation in the treatment of resistant auditory hallucinations in schizophrenia: A meta-analysis. J Clin Psychiatry, 68, 416-21.
252. Anders, M., Dvorakova, J., Rathova, L., et al. 2010. Efficacy of repetitive transcranial magnetic stimulation for the treatment of refractory chronic tinnitus: A randomized, placebo controlled study. Neuro Endocrinol Lett, 31, 238-49.
253. Bae, E., Schrader, L., Machii, K., et al. 2007. Safety and tolerability of repetitive transcranial magnetic stimulation in patients with epilepsy: A review of the literature. Epilepsy Behav, 10, 521-8.
254. Barr, M., Farzan, F., Tran, L., Fitzgerald, P., & Daskalakis, Z. 2011. A randomized controlled trial of sequentially bilateral prefrontal cortex repetitive transcranial magnetic stimulation in the treatment of negative symptoms in schizophrenia. Brain Stimul, [Epub ahead of print].
255. Barker, A., Jalinous, R., & Freeston, I. 1985. Non-invasive magnetic stimulation of human motor cortex. Lancet, 1, 1106-7.
256. Bloch, Y., Harel, E., Aviram, S., et al. 2010. Positive effects of repetitive transcranial magnetic stimulation on attention in ADHD Subjects: A randomized controlled pilot study. World J Biol Psychiatry, 11, 755-8.
257. Borckardt, J., Smith, A., Hutcheson, K., et al. 2006. Reducing pain and unpleasantness during repetitive transcranial magnetic stimulation. J ECT, 22, 259-64.
258. Brighina, F., Piazza, A., Vitello, G., et al. 2004. rTMS of the prefrontal cortex in the treatment of chronic migraine: A pilot study. J Neurol Sci, 15, 67-71.
259. Chen, R., Classen, J., Gerloff, C., et al. 1997. Depression of motor cortex excitability by low-frequency transcranial magnetic stimulation. Neurology, 48, 1398-3.
260. Cohen, R., Boggio, P., & Fregni, F. 2009. Risk factors for relapse after remission with repetitive transcranial magnetic stimulation for the treatment of depression. Depress Anxiety, 26, 682-8.
261. Cohen, H., Kaplan, Z., Kotler, M., et al. 2004. Repetitive transcranial magnetic stimulation of the right dorsolateral prefrontal cortex in posttraumatic stress disorder: A double-blind, placebo-controlled study. Am J Psychiatry, 161, 515-24.
262. Counter, S., Borg, E., Lofqvist, L., & Brismar, T. 1990. Hearing loss from the acoustic artifact of the coil used in extracranial magnetic stimulation. Neurology, 40, 1159-2.
263. Daskalakis, Z., Levinson, A., & Fitzgerald, P. 2008. Repetitive transcranial magnetic stimulation for major depressive disorder: A review. Can J Psychiatry, 53, 555-66.
264. Erfurth, A., Michael, N., Mostert, C., & Arolt, V. 2000. Euphoric mania and rapid transcranial magnetic stimulation. Am J Psychiatry, 157, 835-6.
265. Filipovic, S., Rothwell, J., & Bhatia, K. 2010. Slow (1 Hz) repetitive transcranial magnetic stimulation (rTMS) induces a sustained change in cortical excitability in patients with Parkinson's disease. Clin Neurophysiol, 121, 1129-7.
266. Fitzgerald, P., Benitez, J., Daskalakis, J., et al. 2005. A double-blind sham-controlled trial of repetitive transcranial magnetic stimulation in the treatment of refractory auditory hallucinations. J Clin Psychopharmacol, 25, 358-62.
267. Fitzgerald, P., & Daskalakis, Z. 2011. The effects of repetitive transcranial magnetic stimulation in the treatment of depression. Expert Rev Med Devices, 8, 85-95.
268. Fitzgerald, P., Herring, S., Hoy, K., et al. 2008. A study of the effectiveness of bilateral transcranial magnetic stimulation in the treatment of the negative symptoms of schizophrenia. Brain Stimul, 1, 27-32.
269. Folmer, R., Carroll, J., Rahim, A., Shi, Y., & Hal Martin, W. 2006. Effects of repetitive transcranial magnetic stimulation (rTMS) on chronic tinnitus. Acta Otolaryngol Suppl, 556, 96-101.
270. Garcia, K., Flynn, P., Pierce, K., & Caudle, M. 2010. Repetitive transcranial magnetic stimulation treats postpartum depression. Brain Stimul, 3, 36-41.
271. George, M., Lisanby, S., Avery, D., et al. 2010. Daily left prefrontal transcranial magnetic stimulation therapy for major depressive disorder: A sham-controlled randomized trial. Arch Gen Psychiatry, 67, 507-16.
272. George, M., Wassermann, E., Williams, W., et al. 1995. Daily repetitive transcranial magnetic stimulation (rTMS) improves mood in depression. Neuroreport, 6, 1853-6.
273. George, M. 2010. Transcranial magnetic stimulation for the treatment of depression. Expert Rev Neurother, 10, 1761-2.
274. Greenberg, B., George, M., Martin, J., et al. 1997. Effect of prefrontal repetitive transcranial magnetic stimulation in obsessive-compulsive disorder: A preliminary study. Am J Psychiatry, 154, 867-9.
275. Gross, M., Nakamura, L., Pascual-Leone, A., & Fregni, F. 2007. Has repetitive transcranial magnetic stimulation (rTMS) treatment for depression improved? A systematic review and meta-analysis comparing the recent vs. the earlier rTMS studies. Acta Psychiatr Scand, 116, 165-73.
276. Hallett, M. 2000. Transcranial magnetic stimulation and the human brain. Nature, 406, 147-50.
277. Hamada, M., Ugawa, Y., & Tsuji S. 2009. Effectiveness of rTMS on Parkinson's Disease Study Group, Japan. High-frequency rTMS over the supplementary motor area improves bradykinesia in Parkinson's disease: Subanalysis of double-blind shamcontrolled study. J Neurol Sci, 287, 143-6.
278. Hoffman, R. E., Gueorguieva, R, Hawkins, K. A, Varanko, M., Boutros, N. N., Wu, Y. T., Carroll, K., & Krystal, J. H. 2005. Temporoparietal transcranial magnetic stimulation for auditory hallucinations: Safety, efficacy and moderators in a fifty patient sample. Biol Psychiatry, 58(2): 97-104.
279. Hoffman, R., Hawkins, K., Gueorguieva, R., et al. 2003. Transcranial magnetic stimulation of left temporoparietal cortex and medication-resistant auditory hallucinations. Arch Gen Psychiatry, 60, 49-56.
280. Horvath, J., Perez, J., Forrow, L., Fregni, F., & Pascual-Leone, A. 2011. Transcranial magnetic stimulation: A historical evaluation and future prognosis of therapeutically relevant ethical concerns. J Med Ethics, 37, 137-43.
281. Jaafari, N., Rachid, F., Rotge, J., et al. 2011. Safety and efficacy of repetitive transcranial magnetic stimulation in the treatment of obsessive-compulsive disorder: A review. World J Biol Psychiatry, [Epub ahead of print].
282. Janicak, P., O'Reardon, J., Sampson, S., et al. 2008. Transcranial magnetic stimulation in the treatment of major depressive disorder: A comprehensive summary of safety experience from acute exposure, extended exposure, and during reintroduction treatment. J Clin Psychiatry, 69, 222-32.
283. Jorge, R., Robinson, R., Tateno, A., et al. 2004. Repetitive transcranial magnetic stimulation as treatment of poststroke depression: A preliminary study. Biol Psychiatry, 55, 398-405.
284. Khedr, E.M, Rothwell, J.C., EI-Atar, A. 2009. One-year follow up of patients with chronic tinnitus treated with left temporoparietal rTMS. Eur J Neurol, 16, 404-8.
285. Kim, D. R., Sockol, L., Barber, J. P., Moseley, M., Lamprou, L., Rickels, K., O'Reardon, J. P., & Epperson, C. N. 2011. A survey of patient acdeptability of repetitive transcranial magnetic stimulation (TMS) during pregnancy. J Affect Disord. 129, 385-90.
286. Klein, E., Kreinin, I., Chistyakov, A., et al. 1999. Therapeutic efficacy of right prefrontal slow repetitive transcranial magnetic stimulation in major depression: A doubleblind controlled study. Arch Gen Psychiatry, 56, 315-20.
287. Koch G. 2010. rTMS effects on levodopa induced dyskinesias in Parkinson's disease patients: Searching for effective cortical targets. Restor Neurol Neurosci, 28, 561-8.
288. Kwon, H., Lim, W., Lim, M., et al. 2011. 1-Hz low frequency repetitive transcranial magnetic stimulation in children with Tourette's syndrome. Neurosci Lett, 492, 1-4.
289. Langguth, B., Eichhammer, P., Wiegand, R., et al. 2003. Neuronavigated rTMS in a patient with chronic tinnitus. Effects of 4 weeks treatment. Neuroreport, 14, 977-80.
290. Lee, S. H., Kim, W., Chung, Y. C., Jung, K. H., Bahk, W. M., Jun, T. Y., Kim, K. S., George, M. S., & Chae, J. H. 2005. A double blind study showing that two weeks of daily repetitive TMS over the left or right temporoparietal cortex reduces symptoms in patients with schizophrenia who are having treatment-refractory auditory hallucinations. Neurosci Lett, 376, 177-81.
291. Levkovitz, Y., Roth, Y., Harel, E., et al. 2007. A randomized controlled feasibility and safety study of deep transcranial magnetic stimulation. Clin Neurophysiol, 118, 2730-44.
292. Loo, C., McFarquhar, T., & Walter, G. 2006. Transcranial magnetic stimulation in adolescent depression. Australas Psychiatry, 14, 81-5.
293. Loo, C., McFarquhar T., & Mitchell, P. 2008. A review of the safety of repetitive transcranial magnetic stimulation as a clinical treatment for depression. Int J Neuropsychopharmacol, 11, 131-47.
294. Machii, K., Cohen, D., Ramos-Estebanez, C., & Pascual-Leone, A. 2006. Safety of rTMS to non-motor cortical areas in healthy participants and patients. Clin Neurophysiol, 117, 455-71.
295. Maertens de Noordhout, A. 2006. General principles for clinical use of repetitive transcranial magnetic stimulation (rTMS). Neurophysiol Clin, 36, 97-103.
296. Martin, J., Barbanoj, M., Schlaepfer, T., et al. 2003. Repetitive transcranial magnetic stimulation for the treatment of depression. Systematic review and meta-analysis. Br J Psychiatry, 182, 480-91.
297. Michael, N., & Erfurth, A. 2004. Treatment of bipolar mania with right prefrontal rapid transcranial magnetic stimulation. J Affect Disord, 78, 253-7.
298. Minami, S., Shinden, S., Okamoto, Y., et al. 2011. Repetitive transcranial magnetic stimulation (rTMS) for treatment of chronic tinnitus. Auris Nasus Larynx, 38, 301-6.
299. Mittrach, M., Thünker, J., Winterer, G., et al. 2010. The tolerability of rTMS treatment in schizophrenia with respect to cognitive function. Pharmacopsychiatry, 43, 110-7.
300. Münchau, A., Bloem, B., Thilo, K., et al. 2002. Repetitive transcranial magnetic stimulation for Tourette syndrome. Neurology, 59, 1789-91
301. Nahas, Z., Bohning, D., Molloy, M., et al. 1999. Safety and feasibility of repetitive transcranial magnetic stimulation in the treatment of anxious depression in pregnancy: A case report. J Clin Psychiatry, 60, 50-2.
302. Nedjat, S., & Folkerts, H. 1999. Induction of a reversible state of hypomania by rapid-rate transcranial magnetic stimulation over the left prefrontal lobe. J ECT, 15, 166-8.
303. Niederhofer, H. 2008. Effectiveness of the repetitive Transcranial Magnetic Stimulation (rTMS) of 1 Hz for Attention-Deficit Hyperactivity Disorder (ADHD). Psychiatr Danub, 20, 91-2.
304. O'Connor, M., Brenninkmeyer, C., Morgan, A., et al. 2003. Relative effects of repetitive transcranial magnetic stimulation and electroconvulsive therapy on mood and memory: A neurocognitive risk-benefit analysis. Cogn Behav Neurol, 16, 118-27.
305. O'Connor, M., Jerskey, B., Robertson, E., et al. 2005. The effects of repetitive transcranial magnetic stimulation (rTMS) on procedural memory and dysphoric mood in patients with major depressive disorder. Cogn Behav Neurol, 18, 223-7.
306. O'Reardon, J., Blumner, K., Peshek, A., Pradilla, R., & Pimiento, P. 2005. Long-term maintenance therapy for major depressive disorder with rTMS. J Clin Psychiatry, 66, 1524-8.
307. O'Reardon, J., Fontecha, J., Cristancho, M., & Newman, S. 2007a. Unexpected reduction in migraine and psychogenic headaches following rTMS treatment for major depression: A report of two cases. CNS Spectr, 12, 921-5.
308. O'Reardon, J., Solvason, H., Janicak, P., et al. 2007b. Efficacy and safety of transcranial magnetic stimulation in the acute treatment of major depression: A multisite randomized controlled trial. Biol Psychiatry, 62, 1208-16.
309. Osuch, E., Benson, B., Luckenbaugh, D., et al. 2009. Repetitive TMS combined with exposure therapy for PTSD: A preliminary study. J Anxiety Disord, 23, 54-9.
310. Pascual-Leone, A., & Catalá, M. 1996. Lateralized effect of rapid-rate transcranial magnetic stimulation of the prefrontal cortex on mood. Neurology, 46, 499-502.
311. Pascual-Leone, A., Rubio, B., Pallardó F., & Catalá MD. 1996. Rapid-rate transcranial magnetic stimulation of left dorsolateral prefrontal cortex in drug-resistant depression. Lancet, 348, 233-7.
312. Pascual-Leone, A., Valls-Solé, J., Wassermann, E., et al. 1992. Effects of focal transcranial magnetic stimulation on simple reaction time to acoustic, visual and somatosensory stimuli. Brain, 115, 1045-59.
313. Pascual-Leone, A., Valls-Solé, J., Wassermann, E., & Hallett, M. 1994. Responses to rapidrate transcranial magnetic stimulation of the human motor cortex. Brain, 117, 847-58.
314. Post, A., & Keck, M. 2001. Transcranial magnetic stimulation as a therapeutic tool in psychiatry: What do we know about the neurobiological mechanisms? J Psychiatr Res, 35, 193-215.
315. Praharaj, S., Ram, D., & Aroroa, M. 2009. Efficacy of high frequency (rapid) suprathreshold repetitive transcranial magnetic stimulation of right prefrontal cortex in bipolar mania: A randomized sham controlled study. J Affect Disord, 117, 146-50.
316. Prasko, J., Paskova, B., Zalesky, R., et al. 2006. The effect of repetitive transcranial magnetic stimulation (rTMS) on symptoms in obsessive compulsive disorder. A randomized, double blind, sham controlled study. Neuroendocrinol Lett, 27, 327-32.
317. Pridmore, S., & Belmaker, R. 1999. Transcranial magnetic stimulation in the treatment of psychiatric disorders. Psychiatry Clin Neurosci, 53, 541-8.
318. Prikryl, R., Kasparek, T., Skotakova, S., et al. 2007. Treatment of negative symptoms of schizophrenia using repetitive transcranial magnetic stimulation in a double-blind, randomized controlled study. Schizophr Res, 95, 151-7.
319. Poulet, E., Haesebaert, F., Saoud, M., Suaud-Chagny, M., & Brunelin, J. 2010. Treatment of schizophrenic patients and rTMS. Psychiatr Danub, 22, S143-6.
320. Quintana, H. 2005. Transcranial magnetic stimulation in persons younger than the age of 18. J ECT, 21, 88-95.
321. Rachid, F., & Bertschy, G. 2006. Safety and efficacy of repetitive transcranial magnetic stimulation in the treatment of depression: A critical appraisal of the last 10 years. Neurophysiol Clin, 36, 157-83.
322. Rossi, S., Hallett, M., Rossini, P., Pascual-Leone, A., & The Safety of TMS Consensus Group. 2009. Safety, ethical considerations, and application guidelines for the use of transcranial magnetic stimulation in clinical practice and research. Clin Neurophysiol, 120, 2008-39.
323. Rossini, P., Rossini, L., & Ferreri, F. 2010. Brain-behavior relations: Transcranial magnetic stimulation: A review. IEEE Eng Med Biol Mag, 29, 84-95.
324. Saba, G., Rocamora, J., Kalalou, K., et al. 2004. Repetitive transcranial magnetic stimulation as an add-on therapy in the treatment of mania: A case series of eight patients. Psychiatry Res, 128, 199-202.
325. Sachdev, P., Loo, C., Mitchell, P., McFarquhar, T., & Malhi, G. 2007. Repetitive transcranial magnetic stimulation for the treatment of obsessive compulsive disorder: A double-blind controlled investigation. Psychol Med, 37, 1645-9.
326. Santiago-Rodriguez, E., Cardenas-Morales, L., Harmony, T., Fernandez-Bouzas, A., Porras-Kattz, E., & Hernandez, A. 2008. Repetitive transcranial magnetic stimulation decreases the number of seizures in patients with focal neocortical epilepsy. Seizure, 17, 677-83.
327. Speer, A., Kimbrell, T., Wassermann, E., et al. 2000. Opposite effects of high and low frequency rTMS on regional brain activity in depressed patients. Biol Psychiatry, 48, 1133-41.
328. Strafella, A., Paus, T., Barrett, J., & Dagher, A. 2001. Repetitive transcranial magnetic stimulation of the human prefrontal cortex induces dopamine release in the caudate nucleus. J Neurosci, 21, RC157.
329. Sun, W., Fu, W., Mao, W., Wang, D., & Wang, Y. 2011. Low-frequency repetitive transcranial magnetic stimulation for the treatment of refractory partial epilepsy. Clin EEG Neurosci, 42, 40-4.
330. Teepker, M., Hötzel, J., Timmesfeld, N., et al. 2010. Low-frequency rTMS of the vertex in the prophylactic treatment of migraine. Cephalalgia, 30, 137-44.
331. Wassermann, E. 1998. Risk and safety of repetitive transcranial magnetic stimulation: Report and suggested guidelines from the International Workshop on the Safety of Repetitive Transcranial Magnetic Stimulation, June 5-7, 1996. Electroencephalogr Clin Neurophysiol, 108, 1-16.
332. Yukimasa, T., Yoshimura, R., Tamagawa, A., et al. 2006. High-frequency repetitive transcranial magnetic stimulation improves refractory depression by influencing catecholamine and brain-derived neurotrophic factors. Pharmacopsychiatry, 39, 52-9.
333. Zhang, X., Liu, K., Sun, J., & Zheng, Z. 2010. Safety and feasibility of repetitive transcranial magnetic stimulation (rTMS) as a treatment for major depression during pregnancy. Arch Womens Ment Health, 13, 369-70.
334. Zwanzger, P., Ella, R., Keck, M., Rupprecht, R., & Padberg, F. 2002. Occurrence of delusions during repetitive transcranial magnetic stimulation (rTMS) in major depression. Biol Psychiatry, 51, 602-3.
335. Fink, M. 1979. Convulsive Therapy: Theory and Practice. New York: Raven Press.
336. Kayser, S., Bewernick, B. H., Grubert, C., et al. 2011. Antidepressant effects, of magnetic seizure therapy and electroconvulsive therapy, in treatment-resistant depression. J Psychiatr Res, 45, 569-76.
337. Kosel, M., Frick, C., Lisanby, H. S., Fisch, H. U., & Schlaepfer, T. E. 2003. Magnetic seizure therapy improves mood in refractory major depression. Neuropsychopharmacology, 28, 2045-8.
338. Lisanby, S. H., Luber, B., Finck, A. D., Schroeder, C., & Sackeim, H. A. 2001a. Deliberate seizure induction with repetitive transcranial magnetic stimulation in nonhuman primates. Arch Gen Psychiatry, 58, 199-200.
339. Lisanby, S. H., Schlaepfer, T. E., Fisch, H. U., & Sackeim, H. A. 2001b. Magnetic seizure therapy of major depression. Arch Gen Psychiatry, 58, 303-5.
340. Rowny, S. B., Benzl, K., & Lisanby, S. H. 2009. Translational development strategy for magnetic seizure therapy. Exp Neurol, 219, 27-35.
341. White, P. F., Amos, Q., Zhang, Y., et al. 2006. Anesthetic considerations for magnetic seizure therapy: A novel therapy for severe depression. Anesth Analg, 103, 76-80, table of contents.
342. Burke, M. J., & Husain, M. M. 2006. Concomitant use of vagus nerve stimulation and electroconvulsive therapy for treatment-resistant depression. J ECT, 22, 218-22.
343. Marangell, L. B., Rush, A. J., George, M. S., et al. 2002. Vagus nerve stimulation (VNS) for major depressive episodes: One year outcomes. Biol Psychiatry, 51, 280-7.
344. Nahas, Z., Marangell, L. B., Husain, M. M., et al. 2005. Two-year outcome of vagus nerve stimulation (VNS) for treatment of major depressive episodes. J Clin Psychiatry, 66, 1097-104.
345. Rush, A. J., George, M. S., Sackeim, H. A., et al. 2000. Vagus nerve stimulation (VNS) for treatment-resistant depressions: A multicenter study. Biol Psychiatry, 47, 276-86.
346. Swartz, C. 2009. Electroconvulsive and Neuromodulation Therapies. New York: Cambridge University Press.
347. Tran, Y., Shah, A. K., & Mittal, S. 2011. Lead breakage and vocal cord paralysis following blunt neck trauma in a patient with vagal nerve stimulator. J Neurol Sci, 304, 132-5.
348. Boggio, P. S., Sultani, N., Fecteau, S., et al. 2008. Prefrontal cortex modulation using transcranial DC stimulation reduces alcohol craving: A double-blind, shamcontrolled study. Drug Alcohol Depend, 92, 55-60.
349. Dell'osso, B., Zanoni, S., Ferrucci, R., et al. 2011. Transcranial direct current stimulation for the outpatient treatment of poor-responder depressed patients. Eur Psychiatry, [Epub ahead of print].
350. Fregni, F., Boggio, P. S., Lima, M. C., et al. 2006a. A sham-controlled, phase II trial of transcranial direct current stimulation for the treatment of central pain in traumatic spinal cord injury. Pain, 122, 197-209.
351. Fregni, F., Boggio, P. S., Santos, M. C., et al. 2006b. Noninvasive cortical stimulation with transcranial direct current stimulation in Parkinson's disease. Mov Disord, 21, 1693-702.
352. Fregni, F., Gimenes, R., Valle, A. C., et al. 2006c. A randomized, sham-controlled, proof of principle study of transcranial direct current stimulation for the treatment of pain in fibromyalgia. Arthritis Rheum, 54, 3988-98.
353. Fregni, F., Thome-Souza, S., Nitsche, M. A., et al. 2006d. A controlled clinical trial of cathodal DC polarization in patients with refractory epilepsy. Epilepsia, 47, 335-42.
354. Hummel, F., & Cohen, L.G. 2005. Improvement of motor function with noninvasive cortical stimulation in a patient with chronic stroke. Neurorehabil Neural Repair, 19, 14-9.
355. Martin, D. M., Alonzo, A., Mitchell, P. B., Sachdev, P., Galvez, V., & Loo, C. K. 2011. Fronto-extracephalic transcranial direct current stimulation as a treatment for major depression: An open-label pilot study. J Affect Disord, 134, 459-63.
356. Stagg, C. J., & Nitsche, M. A. 2011. Physiological basis of transcranial direct current stimulation. Neuroscientist, 17, 37-53.
357. Swartz, C. 2009. Electroconvulsive and Neuromodulation Therapies. New York: Cambridge University Press.
358. Tanaka, S.,& Watanabe, K. 2009. (Transcranial direct current stimulation - a new tool for human cognitive neuroscience). Brain Nerve, 61, 53-64.
359. Zheng, X., Alsop, D. C., & Schlaug, G. 2011. Effects of transcranial direct current stimulation (tDCS) on human regional cerebral blood flow. Neuroimage, 58, 26-33.
360. Brown, J. A., Lutsep, H. L., Weinand, M., & Cramer, S. C. 2006. Motor cortex stimulation for the enhancement of recovery from stroke: A prospective, multicenter safety study. Neurosurgery, 58, 464-73.
361. Friedland, D. R., Gaggl, W., Runge-Samuelson, C., Ulmer, J. L., &Kopell, B. H. 2007. Feasibility of auditory cortical stimulation for the treatment of tinnitus. Otol Neurotol, 28(8), 1005-12.
362. Kopell, B. H., Halverson, J., Butson, C. R., et al., 2011. Epidural cortical stimulation (EpCS) of the left dorsolateral prefrontal cortex for refractory major depressive disorder. Neurosurgery, 69, 1015-29.
363. Nahas, Z., Anderson, B. S., Borckardt, J., et al., 2010. Bilateral epidural prefrontal cortical stimulation for treatment-resistant depression. Biol Psychiatry, 67(2), 101-9.
364. Priori, A., & Lefaucheur, J. P. 2007. Chronic epidural motor cortical stimulation for movement disorders. Lancet Neurol, 6(3), 279-86.
365. Velasco, F., Arguelles, C., Carrillo-Ruiz, J. D., et al., 2008. Efficacy of motor cortex stimulation in the treatment of neuropathic pain: A randomized double-blind trial. J Neurosurg, 108(4), 698-706.